Cytomed Therapeutics Ltd balance sheet

At the end of fiscal 2025, Cytomed Therapeutics Ltd had total assets of $6.2m, total liabilities of $879,762 and shareholders' equity of $5.1m. It held $1.6m in cash against $318,456 of debt: net cash of $1.3m.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cytomed Therapeutics Ltd: balance sheet, annual
Fiscal year	2024Dec 2024	2025Dec 2025
Cash and equivalents	3,438	1,630
Receivables	754	1,219
Total current assets	4,392	2,849
Goodwill	0	0
Total assets	7,369	6,210
Total current liabilities	444	551
Short-term debt	28	32
Long-term debt	289	287
Total debt	316	318
Total liabilities	749	880
Shareholders' equity	6,563	5,089
Non-controlling interests and other (assets − liabilities − equity)	—	240
Net debt (negative = net cash)	−3,122	−1,311
Shares outstanding	12m	12m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CLNN vs GDTC CRVO vs GDTC CLDX vs GDTC

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Cytomed Therapeutics Ltd's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cytomed Therapeutics Ltd.